Engineers Gate Manager’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,864
Closed -$14.5M 2651
2025
Q4
$14.5M Buy
47,864
+44,428
+1,293% +$14.5M 0.17% 133
2025
Q3
$1.17M Sell
3,436
-520
-13% -$158K 0.01% 1067
2025
Q2
$958K Sell
3,956
-2,573
-39% -$631K 0.01% 1139
2025
Q1
$1.78M Buy
6,529
+5,154
+375% +$1.2M 0.03% 742
2024
Q4
$254K Sell
1,375
-311
-18% -$63.5K ﹤0.01% 1792
2024
Q3
$379K Buy
+1,686
New +$303K 0.01% 1512
2023
Q3
Sell
-3,454
Closed -$616K 2132
2023
Q2
$616K Buy
3,454
+2,473
+252% +$569K 0.02% 941
2023
Q1
$211K Buy
+981
New +$235K 0.01% 1404
2022
Q4
Sell
-1,709
Closed -$230K 2091
2022
Q3
$230K Buy
+1,709
New +$293K 0.01% 1248
2020
Q1
Sell
-5,002
Closed -$829K 1996
2019
Q4
$829K Buy
+5,002
New +$831K 0.04% 741

Other funds holding ONC

Engineers Gate Manager's ONC Position: Q1 2026 in Review

Engineers Gate Manager sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 47,864 shares — an estimated $14.5M sold.

Engineers Gate Manager first reported a position in ONC in Q4 2019 and held it in 10 quarters. The position peaked at $14.5M in Q4 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Engineers Gate Manager reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 47,864 BeOne Medicines Ltd shares in Q1 2026, an estimated $14.5M.
  • Engineers Gate Manager first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 10 quarters.
  • Engineers Gate Manager's BeOne Medicines Ltd position peaked at $14.5M in Q4 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.